Although ALL associated with SM has been reported only in sporadic cases [38], [39], the presence of the KIT D816V mutation has been documented in lymphocytes from patients with aggressive type of disease or MCL [5], and previous retroviral and transgenic models have demonstrated that Kit D814V has a preferential transforming potential on B cell precursors [40], [41]. This evidence concerns the gene KIT and mantle cell lymphoma.